Medicare Enrolled
Dr. Luis Pineiro, MD
Medical Oncology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pineiro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pineiro?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pineiro
Dr. Luis Pineiro is a medical oncology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pineiro performed 6,413 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Pineiro received a total of $105,530 from 52 pharmaceutical and/or device companies across 343 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pineiro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 43% volume in TX
$105,530 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,413
Medicare services
Top 43% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
3,990 | $30 | $234 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
288 | $62 | $247 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
273 | $10 | $64 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
244 | $6 | $31 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
239 | $94 | $357 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
201 | $8 | $36 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
177 | $7 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
172 | $8 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
157 | $95 | $368 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
81 | $12 | $108 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
73 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
71 | $6 | $34 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
69 | $15 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
69 | $61 | $250 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
58 | $48 | $313 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
58 | $1 | $7 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
55 | $22 | $157 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
54 | $104 | $707 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $137 | $496 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
29 | $11 | $96 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
25 | $89 | $368 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
65.9% high complexity
2.6% medium
31.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$105,530
Total received (2018-2024)
Avg $15,076/year across 7 years
Top 13% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
343
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$10,262
2023
$9,282
2022
$30,616
2021
$1,626
2020
$16,463
2019
$17,170
2018
$20,110
Payments by company (2024)
Alexion Pharmaceuticals, Inc.
$8,300
PFIZER INC.
$180
GENZYME CORPORATION
$166
ADC Therapeutics America, Inc.
$148
Takeda Pharmaceuticals U.S.A., Inc.
$128
E.R. Squibb & Sons, L.L.C.
$127
ABBVIE INC.
$126
Incyte Corporation
$114
Daiichi Sankyo Inc.
$112
JAZZ PHARMACEUTICALS INC.
$102
SANOFI-AVENTIS U.S. LLC
$84
Adaptive Biotechnologies Corporation
$84
Kite Pharma, Inc.
$58
Legend Biotech USA Inc.
$52
Janssen Biotech, Inc.
$50
Karyopharm Therapeutics Inc.
$49
Astellas Pharma US Inc
$45
Novartis Pharmaceuticals Corporation
$42
Rigel Pharmaceuticals, Inc.
$41
Menarini Silicon Biosystems, Inc.
$38
Merck Sharp & Dohme LLC
$37
Stemline Therapeutics Inc.
$28
SOBI, INC
$26
Genmab U.S., Inc.
$25
Kyowa Kirin, Inc.
$22
RECORDATI_RARE_DISEASES_INC.
$22
Genentech USA, Inc.
$20
Acrotech Biopharma Inc.
$18
AstraZeneca Pharmaceuticals LP
$18
Top 3 companies account for 84.3% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$47,524
Kite Pharma, Inc.
$28,464
Seattle Genetics, Inc.
$16,316
Apellis Pharmaceuticals, Inc.
$2,303
Rigel Pharmaceuticals, Inc.
$1,976
Epizyme, Inc.,
$1,024
Astellas Pharma US Inc
$872
Incyte Corporation
$599
GENZYME CORPORATION
$494
Takeda Pharmaceuticals U.S.A., Inc.
$462
ADC Therapeutics America, Inc.
$357
Amgen Inc.
$341
Pharmacyclics LLC, An AbbVie Company
$327
JAZZ PHARMACEUTICALS INC.
$309
PFIZER INC.
$305
Janssen Scientific Affairs, LLC
$296
Celgene Corporation
$266
E.R. Squibb & Sons, L.L.C.
$265
ABBVIE INC.
$262
Janssen Biotech, Inc.
$213
Legend Biotech USA Inc.
$184
SANOFI-AVENTIS U.S. LLC
$184
Daiichi Sankyo Inc.
$179
AstraZeneca Pharmaceuticals LP
$179
Karyopharm Therapeutics Inc.
$172
Adaptive Biotechnologies Corporation
$160
Merck Sharp & Dohme LLC
$154
GlaxoSmithKline, LLC.
$149
Novartis Pharmaceuticals Corporation
$146
KADMON PHARMACEUTICALS LLC
$140
MorphoSys, US Inc.
$113
AbbVie, Inc.
$108
SOBI, INC
$80
Acrotech Biopharma LLC
$66
Seagen Inc.
$65
Sobi, Inc
$49
AbbVie Inc.
$47
Genmab U.S., Inc.
$43
RECORDATI_RARE_DISEASES_INC.
$43
Kyowa Kirin, Inc.
$39
Menarini Silicon Biosystems, Inc.
$38
Genentech USA, Inc.
$38
Stemline Therapeutics Inc.
$28
MENARINI SILICON BIOSYSTEMS, INC.
$22
Ipsen Biopharmaceuticals, Inc
$21
Lilly USA, LLC
$18
Acrotech Biopharma Inc.
$18
Blueprint Medicines Corporation
$16
Pharmacyclics LLC, an AbbVie Company
$15
Biogen, Inc.
$14
Merck Sharp & Dohme Corporation
$13
PFIZER PHARMACEUTICALS LLC
$11
Top 3 companies account for 87.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · BELEODAQ · BESPONSA · BLENREP · BOSULIF · Blincyto · CALQUENCE · CARVYKTI · CRESEMBA · Cellsearch · Columvi · Cresemba · DARZALEX · DEFITELIO · DIFICID · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · ELZONRIS · EMPLICITI · ENJAYMO · EPKINLY · Empaveli · Epkinly · Fabhalta · GAMIFANT · ICLUSIG · IMBRUVICA · INREBIC · Imbruvica · JAKAFI · JAYPIRCA · Kyprolis · LIVTENCITY · MONJUVI · MOZOBIL · NINLARO · OJJAARA · ONUREG · Onivyde · PREVYMIS · PROMACTA · Pomalyst · Poteligeo · REBLOZYL · REZUROCK · RYLAZE · Rezlidhia · Rezurock · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SPINRAZA · SYLVANT · TASIGNA · TAZVERIK · TECVAYLI · Tavalisse · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VONJO · VYXEOS · Vanflyta · Venclexta · XOSPATA · XPOVIO · Xospata · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
90
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pineiro is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pineiro experienced with immune globulin infusion (octagam)?
Based on Medicare claims data, Dr. Pineiro performed 3,990 immune globulin infusion (octagam) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pineiro receive payments from pharmaceutical companies?
Yes. Dr. Pineiro received a total of $105,530 from 52 companies across 343 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pineiro's costs compare to other medical oncologists in Dallas?
Dr. Pineiro's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pineiro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Dallas
Browse medical oncologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology